Gemtuzumab Ozogamicin (Mylotarg®)
Dokument
Fact Sheet
Spezifizierung
Akute Myeloische Leukämie (AML)
» erster Rezidiv
Stand
Januar 2021
Dies ist die aktuell gültige Version des Dokuments
1Gemtuzumab Ozogamicin, AML, first relapse
1 N - number of patients2 RR - remission rate, in %5 OS - overall survival in months14 results for control, results for new therapy15 hazard ratio for new therapy19 Complete Remission Rate (CR + CRp)